Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 45.87 | (485.08) | (738.88)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 115.66 | (477.35) | (725.25)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 285.01 | (356.66) | (505.29)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Agios Pharmaceuticals to sell cancer portfolio t... | 21-Dec-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 37.73 |
Change Today | $ 0.91 |
% Change | 2.47 % |
52 Week High | $61.64 |
52 Week Low | $25.90 |
Volume | 225,176 |
Shares Issued | 58.68m |
Market Cap | $2,214.02m |
RiskGrade | 304 |
Strong Buy | 1 |
Buy | 3 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
14:33 | 100 @ $37.73 |
14:32 | 100 @ $37.77 |
14:32 | 100 @ $37.76 |
14:28 | 100 @ $37.81 |
14:23 | 100 @ $37.83 |
You are here: research